The U.S. Food and Drug Administration said on Friday it would take action against telehealth provider Hims & Hers for its $49 weight-loss pill, including restricting access to the drug's ingredients ...

Hims & Hers (HIMS) shares dropped 16% after-hours as FDA plans to restrict compounded GLP-1 ingredients and HHS referred Hims to DOJ. Hims projected $725M in weight-loss revenue for 2025 from total ...

US Signals Crackdown on Compounded Weight-Loss Drugs; Hims Shares Tumble By Leah Douglas and Siddhi Mahatole Feb 6 (Reuters) - The U.S. Food and Drug Administration said on ‌Friday it would take ...

David lives in Brooklyn where he's spent more than a decade covering all things edible, including meal kit services, food subscriptions, kitchen tools and cooking tips. David earned his BA from ...

Capital at risk. The value of your investments can go up and down, and you may get back less than you invest. Compound interest is earned when interest paid on an account or generated by an investment ...

When it comes to applying skincare products for smooth, youthful-looking skin, it’s easy to overlook our body. But did you know the delicate skin of your hands are likely to show signs of aging, ...

ConsumerAffairs is not a government agency. Companies displayed may pay us to be Authorized or when you click a link, call a number or fill a form on our site. Our content is intended to be used for ...

Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite new rules limiting their manufacture, ...

NEW YORK, Feb 5 (Reuters) - Online telehealth company Hims and Hers Health will start offering compounded copies of Novo Nordisk's new Wegovy weight-loss pill at an introductory price of $49 per month ...